---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-004766"
form_type: "8-K"
ticker: "ACTU"
cik: "0001652935"
company_name: "ACTUATE THERAPEUTICS, INC."
filed_at: "2025-06-26T23:59:59+00:00"
generated_at: "2026-05-18T17:57:09.181190+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Actuate Therapeutics raises ~$4.7M in private placement of common stock and warrants

## Summary
- Gross proceeds of approx. $4.7M from sale of 666,497 shares at $7.00/share and warrants to purchase 666,497 shares.
- Warrants exercisable at $7.00 for 20 days after Milestone Date (FDA Breakthrough Therapy or registration determination for elraglusib).
- Bios 2024 Co-Invest, LP (affiliated with Chairman Dr. Aaron G.L. Fletcher) purchasing 71,428 shares and warrants for ~$500K.
- Closing expected on or before June 30, 2025; proceeds for working capital and general corporate purposes.
- Registration rights agreement requires filing resale registration statement by August 9, 2025.

## SEC filing metadata
- accession: 0001683168-25-004766
- form_type: 8-K
- ticker: ACTU
- cik: 0001652935
- company_name: ACTUATE THERAPEUTICS, INC.
- filed_at: 2025-06-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652935/000168316825004766/0001683168-25-004766-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652935/000168316825004766/actuate_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-004766
- JSON: https://secwatch.observer/filing/0001683168-25-004766.json
- Plain text: https://secwatch.observer/filing/0001683168-25-004766.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.